Properties
Description
Tarloxotinib bromide is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR/HER2.
Molecular Formula
C24H24Br2ClN9O3
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Tarloxotinib bromide can be used to study its efficacy as a prodrug EGFR/HER2 inhibitor in cancer treatment.
